External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home SITC 2023
Roche and Genentech at

SITC 2023

November 01 - November 05
San Diego, USA
sitcancer.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
04:00 PM
Duration 10hrs San Diego, USA
Identification of non-squamous NSCLC molecular subtypes and association with outcomes in the phase 3 IMpower150 study of 1L atezolizumab ± bevacizumab + carboplatin-paclitaxel in metastatic NSCLC
Tianshi Lu, Mark Socinski, Martin Reck, Howard Jack West, Federico Cappuzzo, Fabrice Barlesi, Robert M Jotte, Soeren Mueller, Habib Hamidi, Assaf Amitai, Hartmut Koeppen, David S Shames, Marcus Ballinger, Minu K Srivastava, Barzin Nabet
Oncology | Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 10hrs San Diego, USA
A Phase I study of a tumor-targeted fibroblast activation protein (FAP)-CD40 agonist (RO7300490) in patients with advanced solid tumors
Ignacio Melero, Julia Lostes Bardaji, Iben Spanggaard, Dae Ho Lee, James Spicer, Fiona Thistlethwaite, Stefan Symeonides, Do-Youn Oh, Antoine Hollebecque, Corinne Rusterholz, Olivera Cirovic, Yvonne Zhao,Nicole A Kratochwil, Bernhard Reis, Alexandra Epp, Georgios Kazantzidis, Victor Moreno
Oncology | Solid Tumours

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 10hrs San Diego, USA
TIGIT and PD-L1 co-blockade promotes functional differentiation and clonal expansion of antitumor CD8+ T cells resistant to exhaustion programming
Katherine N. Nutsch, Karl Banta, Thomas D. Wu, Charles Tran, Stephanie Mittman, Ellen Duong, Barzin Nabet, Yan Qu, Namrata S. Patil, Eugene Y. Chiang, Ira Mellman
Oncology | Solid Tumours - Non-Small Cell Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:55 PM
Duration 120mins Presented during Session: Stromal Cells and TLS
IMpower110: Tertiary lymphoid structures (TLS) and clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with first-line atezolizumab or chemotherapy
Minu K. Srivastava, VelimirGayevskiy, VyMa, Ivette Estay, Miguel Lopez de Rodas, Barani Kumar Rajendran, Tien Hoang, Marcus Ballinger, Reena Amin, Roy S. Herbst, Filippo De Marinis, Giuseppe Giaccone, Jacek Jassem, David Spigel, Kurt Schalper, Hartmut Koeppen, David S. Shames, Robert Johnston, Jennifer Giltnane, Barzin Y. Nabet
Oncology | Non-Small Cell Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.